External validation of the barcelona magnetic resonance imaging predictive model for detecting significant prostate cancer including men receiving 5-alpha reductase inhibitors.

Juan MoroteÁngel Borque-FernandoLuis M EstebanNatàlia PicolaJesús Muñoz-RodriguezNahuel PaesanoXavier Ruiz-PlazasMarta V Muñoz-RiveroAna CelmaGemma García-de ManuelBerta MiróJosé M AbascalPol Servian

Published in: World journal of urology (2024)

The BCN-MRI PM has achieved successful validation in Catalonia and, notably, for the first time, in men undergoing 5-ARI treatment.

Keyphrases

magnetic resonance imaging
prostate cancer
contrast enhanced
middle aged
radical prostatectomy
computed tomography
particulate matter
air pollution
diffusion weighted imaging
polycyclic aromatic hydrocarbons